Chinese Medicine

USA Chinese biotech and pharmaceuticals ETF listed on Nasdaq Loncar Investments, a Kansas-based investment firm, is teaming up with white-labeller Exchange Traded Concepts to list a new fund that gives a more granular play on China’s booming healthcare industry. The Loncar China BioPharma ETF (CHNA) will track an index built by Loncar that measures the performance of Chinese pharmaceutical and …

Innovative Asia

Hong Kong Premia Partners lists innovative tech ETFs Hong Kong-based ETF newcomer Premia Partners is building out its thematic and smart beta offering, listing two new ETFs that focus on Asian niches. Premia Asia Innovative Technology ETF (3181, 918) Premia Emerging ASEAN Titans 100 ETF (2810, 9810) The Asian innovation ETF uses a FactSet index to look at Asian companies R&D …

Bad Dracula

USA BMO lists leveraged FANG ETNs For those thinking it is high time the tech giants came down to earth, Canadian banking giant BMO is listing three new ETNs that offer inverse and leveraged exposure to the FANGs “microsector”. BMO REX MicroSectors FANG Index 2X Leveraged ETN (FNGO) BMO REX MicroSectors FANG Index -2X Inverse Leveraged ETN (FNGZ) BMO REX …

BlackRock Guts Fixed Income Fees

USA Aptus lists actively managed leveraged momentum multi-asset ETF of ETFs with bond laddering to protect against downside risk How’s that for a verbose title? Alabama-based Aptus Capital Advisors is listing a new actively managed ETF of ETFs that seeks leveraged exposure to momentum stocks, while buying laddered corporate bonds to reduce risk. The Aptus Defined Risk ETF (DRSK) will use two strategies: …

Structured not Stirred

USA Innovator ETFs lists annuity-like ETFs, offering defined outcomes Innovator ETFs, an Illinois-based provider backed by PowerShares founder Bruce Bond, is listing a suite of defined outcome ETFs that lock in certain returns on the S&P 500. The new ETFs buy and sell options to protect investors from downside risk while capping the gains they can receive. Innovator S&P 500 …